Cervical cancer is the fourth most frequent cancer in women with a particularly high burden in low-and middle-income countries(LMICs).
Our commitment to cervical cancer covers the entire screening and triage portfolio for clinicians to identify the person with highest risk among asymptomatic population.
HPV Test
HPV-based screening, which is more sensitive regarding the detection of pre-cancerous lesions compared with cytology-based testing, has been recommended in guidelines issued by WHO and many countries
.
Liquid-Based Cytology Test
Papanicolaou (Pap) test became the primary method to screen for cervical cancer since 1950s and is utilized in many countries worldwide.
Cytology p16/Ki-67 Dual Staining
Meta-analysis showed that p16/Ki-67 duaI staining is much more specific for the detection of CIN3 in women with minor abnormal cytology than HR-HPV testing with acceptable or minimal loss of sensitivity.
|
|
YOUYI Bioscience Ltd.
Do right things for health!
Contact Us
Address: Rm 805, Building B1, No.28, Youtian Road, Anliang Community, Yuanshan Subdistrict, Longgang District, Shenzhen, P.R.ChinaTEL: +86-755-28262346Overseas Sales Hotline:+852-6760748Email: service200@youyibio.com